相关实验视频
Updated: Jun 22, 2025

09:59
Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
25.1K
洞察外体在制药创新和精密医学中的功能动态和挑战
Anu Sharma1, Anita Yadav1, Aparajita Nandy1
1McGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15219, USA.
Pharmaceutics
|June 27, 2024
概括
外体,细胞中的微小囊泡,由于稳定性和向性传递,显示出作为治疗方法的希望. 然而,孤立和监管方面的挑战阻碍了它们的临床使用,需要进一步的研究才能广泛采用.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 外体,内体源外细胞囊泡,由于稳定性,低免疫性和向传递,被认为具有治疗潜力.
- 它们的固有特性使它们成为药物输送,再生医学和诊断的理想候选者.
研究的目的:
- 在制药和精密医学中批判性地评估基于外体的模式的潜力.
- 审查当前的研究,解决外体隔离和监管途径的挑战.
- 讨论外体治疗的临床转化所需的进展.
主要方法:
- 对基于外体细胞的治疗方法的当前研究的文献综述.
- 分析影响外体组利用的科学和监管挑战.
- 讨论临床整合的未来进展.
主要成果:
- 外体提供精确的生物分子货物传递,用于药物输送,再生医学和诊断.
- 预计外体细胞治疗的市场将大幅增长.
- 主要障碍包括缺乏标准化的隔离协议和复杂的监管导航,特别是FDA指南.
结论:
- 基于外体的疗法具有变革潜力,但面临科学和监管障碍.
- 解决隔离标准化和监管复杂性的问题对于临床翻译至关重要.
- 需要进一步的研究和开发,以将外体系统纳入主流临床实践.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K

